SG Morning Highlights: Singapore Q3 private home prices up 3.4% from Q2, led by 7% jump in suburban condos
Good morning mooers! Here are things you need to know about today's Singapore:
●Singapore shares opened lower on Monday; STI down 0.26%
●Singapore Q3 private home prices up 3.4% from Q2, led by 7% jump in suburban condos
●Stocks to watch: ESR-Logos Reit, CapitaLand Ascendas Reit
●Latest share buy back transactions
-moomoo News SG
Market Trend
Singapore shares opened lower on Monday. The $FTSE Singapore Straits Time Index(.STI.SG$ decreased 0.26 per cent to 3,122.18 as of 9.33am.
Advancers / Decliners is 75 to 166, with 223.08 million securities worth S$194.93 million changing hands.
Breaking News
There was a 7 per cent surge in prices of non-landed homes in the outside central region, which grew 2.1 per cent in the previous quarter.
PRIVATE residential property prices rose 3.4 per cent in the third quarter after growing 3.5 per cent in the second quarter of 2022, the Urban Redevelopment Authority (URA) flash estimates show.
The increase was led by a 7 per cent surge in prices of non-landed homes in the outside central region, which grew 2.1 per cent in the previous quarter.
This was followed by a 2.5 per cent rise in condo prices in the rest of central region, which rose 6.4 per cent in Q2, and a 2.3 per cent increase in the core central region prices, compared to the 1.9 per cent rise in the previous quarter.
Stocks to Watch
$ESR-LOGOS REIT(J91U.SG$: ESR Group, on Sept 30, announced that it is in the process of acquiring a further 7.7% stake in the manager of SGX-listed ESR-LOGOS REIT (ELOG) from Mitsui & Co.
With the acquisition of Mitsui’s stake, ESR now owns 99% of the ELOG manager.
Prior to this transaction, ESR had acquired 654,546 shares in the ELOG manager from Shanghai Summit, a company wholly-owned by Tong Jinquan, on July 27. The July transaction had already brought ESR’s stake in the ELOG manager to 91.3%.
$CapLand Ascendas REIT(A17U.SG$: The manager of CapitaLand Ascendas REIT (CLAR), formerly known as Ascendas REIT, says it has signed a full building lease agreement with Crinetics Pharmaceuticals, Inc. for its new global headquarters at 6055 Lusk Boulevard, San Diego, United States.
Crinetics Pharmaceuticals is a NASDAQ-listed clinical stage pharmaceutical company focused on the discovery, development, and commercialisation of novel therapeutics for rare endocrine diseases and endocrine-related tumours.
The property is located in Sorrento Mesa, one of the top life science submarkets within the United States.
Under the agreement, CLAR will convert the office property into a premier life sciences property at an estimated cost of US$40.0 million ($56.4 million).
Latest Share Buy Back Transactions
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
